Study analyzes mortality risks among pro athletes

May 24, 2019

Professional football players appear to have a somewhat elevated risk of death, including higher risk of succumbing to cardiac and neurodegenerative diseases, compared with professional baseball players of similar age, according to new research.

The findings raise important questions about sport-specific differences in disease development and the mechanisms that drive the elevated risk. Such mechanisms mandate further research, the investigators said.

This particular study was not designed to elucidate the reasons for the elevated risk seen in NFL players, nor was it intended to examine the mechanisms that fuel disease development in these athletes, the investigators caution.

The analysis--the first head-to-head comparison between elite professional athletes of similar ages--is published May 24 in JAMA NetworkOpen. The work was conducted by investigators at the Harvard T.H. Chan School of Public Health, Harvard Medical School and Spaulding Rehabilitation Hospital.

The findings are based on a retrospective analysis of death rates and causes of death in 3,419 NFL (National Football League) and 2,708 MLB (Major League Baseball) players over more than 30 years.

There were 517 deaths among NFL players and 431 deaths among MLB players between 1979 and 2013. The difference translates into a 26 percent higher mortality among football players compared with baseball players. NFL players had a nearly threefold greater likelihood of dying of neurodegenerative conditions, compared with MLB players. They also had a nearly 2.5-fold risk of dying from a cardiac cause, the study showed. There were 498 deaths stemming from cardiovascular causes among the NFL players and 225 such deaths among MLB players. The study identified 39 deaths from neurodegenerative conditions such as Alzheimer's disease, ALS and Parkinson's in NFL players and 16 such deaths in MLB players. There were 11 suicides among the NFL group and five in the MLB group.

Extrapolating these differences into absolute numbers, the researchers said, the elevated risk would translate into one additional death from a neurodegenerative disease per 1,000 NFL players by age 55 rising to 11 additional neurodegenerative deaths by age 75, compared with MLB players. Cardiovascular causes would account for 16 additional deaths per 1,000 NFL players by age 55 and rising to 77 additional deaths by age 75 in NFL players, compared with MLB players.

"Even a single preventable or premature death is one too many, so it is critical for scientists and clinicians to pursue further research into teasing out the reasons behind this increased mortality," said study senior author Marc Weisskopf, the Cecil K. and Philip Drinker Professor of Environmental Epidemiology and Physiology at the Harvard Chan School. "However, it is important to remember that the actual number of additional deaths from neurodegenerative diseases among football players remains low."

The number of excess deaths (77) stemming from cardiovascular illness was markedly higher, which may be due to several factors, including higher body-mass index among football players and the sheer prevalence of cardiovascular illness, the researchers said. Indeed, cardiovascular disease is the leading cause of death in the United States and worldwide.

The results point to the existence of sport-specific differences in sport-related injuries and athlete conditioning as important contributors to disease development. For example, head trauma, repetitive head injuries and subconcussive blows in NFL athletes may contribute to the onset of pathologies that eventually lead to certain neurologic conditions, the researchers said. Football players' larger overall size and greater body-mass index, which renders them more susceptible to hypertension and sleep apnea, can also be contributors, the researchers added.

For their analysis, the researchers used vital statistics obtained from two national databases--the National Institute for Occupational Safety and Health for information on NFL players and the Lahman Baseball Database of MLB players, an index combining data on MLB and predecessor leagues no longer in existence. The researchers then cross-referenced death outcomes from these two databases with information obtained from the National Death Index, a federal database that tracks causes of death occurring within the United States.

Past research has compared health status and mortality outcomes between professional football players and the general population, but such comparisons are inherently flawed because football players are overall healthier than members of the general population. Past comparisons between NFL players and the general population have showed a lower overall mortality rate among football players but an increased risk for death from neurologic disease.

In a somewhat more meaningful comparison, a recent study analyzed death outcomes among NFL players and replacement football players who played during an NFL players' strike. This research found a small but statistically insignificant increase in death rates among NFL players.

A comparison between two groups of professional athletes with similar physical characteristics, levels of conditioning and overall health status can tease out more meaningful differences in risk directly attributable to playing one sport versus the other, the investigators said.

Understanding whether and how certain sport-specific activities may fuel the development of diseases is essential to informing appropriate interventions, the researchers said.

"A life in pro football may have lifelong consequences, particularly in the domains of cardiac and neurologic health," said Ross Zafonte, the Earle P. and Ida S. Charlton Professor and head of the Department of Physical Medicine and Rehabilitation at Harvard Medical School.

"Elucidating sports-specific aspects of disease development is critical for our ability to inform best strategies to maintain optimal player health and prevent disease," Zafonte added. "This study illuminates the importance of former players taking an active step in seeking a comprehensive health evaluation from their doctor. They should ensure they are closely monitored for both cardiovascular and neurological issues, some of which may be treatable."
-end-
Co-investigators included Vy Nguyen, Jarvis Chen, Kale Kponee, Sabrina Paganoni, Alvaro Pascual-Leone, Frank Speizer, Aaron Baggish, Herman Taylor, Lee Nadler, Theodore Courtney and Ann Connor. Zafonte also serves as chief of physical medicine and rehabilitation at Massachusetts General Hospital, Brigham and Women's Hospital, and as senior vice president of medical affairs research and education at Spaulding Rehabilitation Network.

Funding disclosures: This work was supported by the Spaulding Research Institute and by grant P30 ES 000002 from the National Institutes of Health. Nguyen was supported by grant T42 0H008416 from the National Institute for Occupational Safety and Health. Zafonte, Pascual-Leone, Speizer, Baggish, Taylor, Nadler, Weisskopf, Courtney and Connor received support from the Football Players Health Study at Harvard University.

For other relevant and/or conflict-of-interest disclosures: doi:10.1001/jamanetworkopen.2019.4223

Harvard Medical School

Related Sleep Apnea Articles from Brightsurf:

Sleep apnea may be risk factor for COVID-19
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic.

Untreated sleep apnea is associated with flu hospitalization
As we approach flu season, adults with obstructive sleep apnea may want to take extra precautions.

Losing tongue fat improves sleep apnea
Using magnetic resonance imaging (MRI) to measure the effect of weight loss on the upper airway in obese patients, researchers found that reducing tongue fat is a primary factor in lessening the severity of OSA.

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows.

New evidence on the association of shortened sleep time and obstructive sleep apnea with sleepiness and cardiometabolic risk factors
A new study in the journal CHEST® may change the way we think about sleep disorders.

Synthetic cannabis-like drug reduces sleep apnea
A synthetic cannabis-like drug in a pill reduced apnea and daytime sleepiness in the first large multi-site study of a drug for apnea.

Inflammation may precede sleep apnea, could be treatment target
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

Concerns that sleep apnea could impact healthspan
The number of people with obstructive sleep apnea has steadily increased over the past two decades.

Sleep apnea and insomnia combination linked with depression
A new study found that men with sleep apnea and insomnia have a higher prevalence and severity of depressive symptoms than men with sleep apnea or insomnia alone.

Anti-nausea drug could help treat sleep apnea
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual meeting in Boston.

Read More: Sleep Apnea News and Sleep Apnea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.